Codexis Reports Financial Results for the First Quarter of 2016
May 09, 2016 16:05 ET
|
Codexis, Inc.
Revenues increase 18% to $8.0 million on significant growth in core biocatalyst R&D revenues and product sales Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., May...
Codexis to Hold 2016 First Quarter Conference Call on May 9
May 02, 2016 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2016 financial results after...
Codexis Completes CodeEvolver® Technology Transfer to GSK; Earns $7.5 Million Milestone Payment
May 02, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the completion of the third and final Wave in the transfer of...
Codexis Reports 2015 Fourth Quarter and Full Year Financial Results
March 03, 2016 16:05 ET
|
Codexis, Inc.
Meets 2015 Financial Guidance and Introduces 2016 Financial Guidance Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc....
Codexis Adds Life Sciences Industry Veteran David V. Smith to Its Board of Directors
March 03, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the...
Codexis to Hold 2015 Fourth Quarter and Full Year Conference Call on March 3
February 25, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2015...
Codexis Signs Multi-year Extension of Contract with Merck to Supply Enzyme Used in Manufacture of Sitagliptin
December 18, 2015 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 18, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemicals industry, announces the signing...
Codexis to Present at LD Micro Main Event
November 24, 2015 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces that management...
Codexis Reports Financial Results for the Third Quarter of 2015
November 04, 2015 16:05 ET
|
Codexis, Inc.
Records net income of $5.4 million on revenues of $17.4 million
Recognizes licensing agreement milestone payments totaling $11.5 million from GSK and Merck
Affirms 2015 revenue guidance and...
Codexis to Hold 2015 Third Quarter Conference Call on November 4
October 28, 2015 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it will report third quarter 2015 financial results...